Global investment firm KKR & Co. Inc. will pick up a controlling stake in Mumbai-based branded formulation player JB Chemicals and Pharmaceuticals (JB Chemicals).
As part of the deal, KKR will acquire stake from the founding Mody family at Rs 745 per share (or 5 per cent premium to the closing price of Rs 715 on the BSE).
According to a BSE notification, KKR has entered into an agreement to acquire 41.7 million equity shares of JB Chemicals, representing 54 per cent, from the promoters of the company, said a company statement on Thursday.
After this transaction, an open offer